A critical discovery in cancer study is emerging with the use of VHH fragments to re-engage damaged p53. This vital cancer suppressor protein is frequently lost in several kinds of malignancies, resulting uncontrolled https://bookmarkingdelta.com/story21909553/nanobodies-reactivate-tumor-suppressor-p53-the-new-pathway-for-malignant-treatment